文献速递心胸血管麻醉

TEG 6s肝素中和卡用于心血管手术患者止血评估的验证

TEG ® 6s Heparin Neutralization Cartridge for Hemostatic Assessment of Patients Undergoing Cardiovascular Surgery.
PubMed 文献 · Anesthesiology · 2025-09-18

这项多中心观察性研究纳入185例计划使用普通肝素的心血管手术或介入患者,共采集543份血样,比较TEG 6s肝素中和卡与已验证的枸橼酸多通道卡。结果显示两种卡对应检测的Deming回归斜率约为1.0,Pearson相关系数0.79至0.96,功能性纤维蛋白原与肝素酶检测和血浆纤维蛋白原Spearman相关系数为0.68。

要点

  • TEG 6s肝素中和卡与枸橼酸多通道卡对应检测高度一致。
  • 功能性纤维蛋白原加肝素酶检测与血浆纤维蛋白原相关性中等。
  • 加肝素酶后RapidTEG和功能性纤维蛋白原可分析样本数增加。

核心结论

  • 本研究为TEG 6s肝素中和卡在心血管手术或介入患者床旁凝血检测提供了临床验证。
  • 仍需以临床终点为目标的前瞻性试验来确定该卡的临床效用。

研究设计与样本

  • 多中心观察性研究,纳入计划使用普通肝素的成年心血管手术或侵入性心脏操作患者。
  • 共185例患者,其中113例为体外循环心血管手术,72例为非体外循环心血管操作;共采集543份样本。
  • 在肝素给药前、给药后及肝素逆转后(未用鱼精蛋白者为操作结束时)采血。

主要发现

  • 肝素中和卡与枸橼酸多通道卡对应检测的Deming回归斜率等于或约等于1.0。
  • 上述对应检测的Pearson相关系数范围为0.79至0.96。
  • 功能性纤维蛋白原加肝素酶检测与血浆纤维蛋白原(Clauss法)的Spearman相关系数为0.68。
  • RapidTEG和功能性纤维蛋白原检测加肝素酶后,可分析样本数较不加肝素酶时增加。

关键数值与推荐

  • 肝素中和卡上的高岭土检测与高岭土加肝素酶检测,分别与枸橼酸多通道卡上相同检测进行比较。
  • RapidTEG加肝素酶检测与枸橼酸多通道卡上的高岭土加肝素酶检测进行比较。
  • 功能性纤维蛋白原加肝素酶检测与血浆纤维蛋白原水平(Clauss法)进行比较。

临床怎么用

  • 在肝素化心血管手术或介入患者中,可用TEG 6s肝素中和卡进行床旁凝血检测以评估止血状态。

局限性

  • 本研究为观察性研究,未报告以临床终点为目标的前瞻性验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Heparin administration can limit viscoelastic testing. The cartridge-based TEG ® 6s thromboelastography system (Haemonetics Corp., USA) uses heparinase to neutralize heparin effects. This study aimed to validate the TEG 6s global hemostasis-heparin neutralization cartridge, recently cleared by the U.S. Food and Drug Administration, in heparinized patients undergoing cardiovascular surgery with cardiopulmonary bypass or cardiovascular procedures without cardiopulmonary bypass and liver transplantation. METHODS: Adult patients undergoing cardiovascular surgery/invasive cardiac procedures with planned use of unfractionated heparin were included in this multicenter observational study. Blood samples were obtained before heparin administration, after heparin administration, and after heparin reversal (or at the end of the procedure when protamine was not administered). The kaolin and the kaolin with heparinase assays on the heparin neutralization cartridge were compared with their identical counterparts on the clinically validated TEG 6s citrated multichannel cartridge; the RapidTEG TM with heparinase assay was evaluated against the kaolin with heparinase assay on the citrated multichannel cartridge. The functional fibrinogen with heparinase assay was evaluated against plasma fibrinogen levels (Clauss assay). Comparison analysis was performed using Deming linear regression or Pearson/Spearman correlation. RESULTS: A total of 543 samples were collected from 185 patients (113 cardiovascular surgery with cardiopulmonary bypass; 72 cardiovascular procedures without cardiopulmonary bypass). Deming regression slopes were equal to/approximately 1.0 for comparisons between assays on the heparin neutralization and citrated multichannel cartridges; Pearson correlation coefficients ranged from 0.79 to 0.96. The functional fibrinogen with heparinase assay was correlated with plasma fibrinogen levels (Spearman correlation, 0.68). Addition of heparinase to the RapidTEG and functional fibrinogen assays resulted in a higher number of analyzable samples compared to these assays without heparinase. CONCLUSIONS: This study provided clinical validation for the TEG 6s heparin neutralization cartridge for point-of-care coagulation testing in patients undergoing cardiovascular surgeries or procedures. Further prospective trials with clinical endpoints are needed to determine the clinical utility of this cartridge.

来源:Anesthesiology,查看原文。版权归原作者所有。

引用

  1. Adelmann D, Hartmann J, Moore HB, et al. TEG ® 6s Heparin Neutralization Cartridge for Hemostatic Assessment of Patients Undergoing Cardiovascular Surgery. Anesthesiology. 2025. PMID: 40965969. doi:10.1097/ALN.0000000000005759

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。